We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novavax Says It Will Meet U.S. Needs for COVID-19 Vaccine, but Is Aiming Higher
Novavax Says It Will Meet U.S. Needs for COVID-19 Vaccine, but Is Aiming Higher
Novavax plans to have enough COVID-19 vaccine manufacturing capacity to meet U.S. demand at a minimum, but the Maryland-based vaccine developer is also looking to be able to supply billions of doses next year, the company’s CEO said.